Anti-virus preparation produced from moutan barks and production method of anti-virus preparation produced from moutan barks

A Cortex Moutan, antiviral technology, applied in antiviral agents, pharmaceutical formulations, allergic diseases, etc., can solve problems such as difficulty in obtaining natural pharmaceutical ingredients and hindering efficacy in drug screening.

Inactive Publication Date: 2020-06-05
山西纳安健康科技有限公司
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There are many types of traditional Chinese medicines with antiviral effects, but the difficulty in obtaining the ingre

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0050] An antiviral preparation prepared based on Cortex Moutan, in parts by weight, the antiviral preparation comprises 20 parts of ethanol extract of Cortex Moutan, 10 parts of ethanol extract of Dracaena dracaena, 15 parts of ethanol extract of Prunella vulgaris, 5 parts of Dandelion ethanol extract, 7 parts of Pulmonaria ethanol extract, 3 parts of Eucalyptus ethanol extract, 3 parts of Meconopsis ellipsis water extract, 5 parts of purslane water extract and 2 parts of Magnolia magnolia water extract .

[0051] Wherein, the preparation method of above-mentioned component comprises the following steps:

[0052] (1) Preparation of Cortex Moutan ethanol extract:

[0053] (1.1) After washing and drying the Cortex Moutan, grind it into Cortex Cortex Moutan powder with a particle size of 90 mesh;

[0054] (1.2) Mix the Cortex Moutan powder and ethanol with a volume fraction of 85% in a weight ratio of 1:4, put it in an ultrasonic water bath at 60°C and 320W for 90 minutes, fil...

Embodiment 2

[0066] An antiviral preparation prepared based on Cortex Moutan, in parts by weight, the antiviral preparation comprises 25 parts of ethanol extract of Cortex Moutan, 13 parts of ethanol extract of Dracaena dracaena, 20 parts of ethanol extract of Prunella vulgaris, 7 parts of Dandelion ethanol extract, 12 parts of Pulmonaria ethanol extract, 4 parts of Eucalyptus ethanol extract, 4 parts of Meconopsis ellipsis water extract, 8 parts of purslane water extract and 5 parts of Magnolia magnolia water extract .

[0067] Wherein, the preparation method of above-mentioned component is with embodiment 1.

Embodiment 3

[0069] An antiviral preparation prepared based on Cortex Moutan, in parts by weight, the antiviral preparation comprises 26 parts of ethanol extract of Cortex Moutan, 16 parts of ethanol extract of Dracaena dracaena, 23 parts of ethanol extract of Prunella vulgaris, 7 parts of Dandelion ethanol extract, 13 parts of Pulmonaria ethanol extract, 4 parts of Eucalyptus ethanol extract, 5 parts of Meconopsis ellipsis water extract, 7 parts of purslane water extract and 6 parts of Magnolia magnolia water extract .

[0070] Wherein, the preparation method of above-mentioned component is with embodiment 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Granularityaaaaaaaaaa
Granularityaaaaaaaaaa
Granularityaaaaaaaaaa
Login to view more

Abstract

The invention discloses an anti-virus preparation produced from moutan barks and a production method of the anti-virus preparation produced from the moutan barks, and particularly relates to the fieldof anti-virus preparations. The anti-virus preparation comprises, in parts by weight, 20-30 parts of an ethanol extract of the moutan barks, 10-17 parts of an ethanol extract of tuberous roots of pleomele angustifolia, 15-25 parts of an ethanol extract of ajuga nipponensis, 5-9 parts of an ethanol extract of dandelions, 7-16 parts of an ethanol extract of tripterospermum chinense and 3-5 parts ofan ethanol extract of leaves and fruits of eucalyptus globulus. The anti-virus preparation produced from the moutan barks and the production method of the anti-virus preparation produced from the moutan barks have the advantages that the components are few, transcription of viruses can be inhibited, and the immunity of human bodies can be improved.

Description

technical field [0001] The invention relates to the field of antiviral preparations, in particular to an antiviral preparation prepared based on Cortex Moutan and a preparation method thereof. Background technique [0002] Viruses are the main culprits of infectious diseases, which are extremely harmful and have a wide impact. Today, with the rapid development of science, it is still one of the biggest puzzles faced by developed countries and many developing countries. Especially at the end of 2019, due to the wanton spread of the new coronavirus, it has brought huge economic losses to the people of the world. [0003] In order to inhibit the transcription and further spread of the virus, a variety of traditional Chinese medicines and synthetic chemical drugs have appeared on the market. However, since viruses mutate much faster than the development of new drugs, and are prone to resistance to synthetic chemical drugs, natural drugs have sprung up in the drug market, playi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/88A61K9/48A61P31/16A61P37/04
CPCA61K9/48A61K36/185A61K36/288A61K36/51A61K36/53A61K36/575A61K36/61A61K36/65A61K36/66A61K36/71A61K36/88A61K2236/331A61K2236/333A61P31/16A61P37/04A61K2300/00
Inventor 渠志灿李晓君丁东源梁锐谭永兰
Owner 山西纳安健康科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap